|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
6
|
|
gptkbp:bfsParent
|
gptkb:Tagamet
|
|
gptkbp:approves
|
gptkb:1977
|
|
gptkbp:brand
|
gptkb:Tagamet
gptkb:Cimetidine
|
|
gptkbp:clinical_trial
|
studies on efficacy
studies on safety
studies on dosage
studies on interactions
|
|
gptkbp:contraindication
|
liver disease
renal impairment
|
|
gptkbp:current_use
|
peptic ulcer disease
acid reflux
heartburn
dyspepsia
|
|
gptkbp:dosage_form
|
over-the-counter
|
|
gptkbp:duration
|
6 to 8 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:form
|
gptkb:tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Tagamet HB
|
|
gptkbp:indication
|
gptkb:Zollinger-Ellison_syndrome
prevention of ulcers
|
|
gptkbp:ingredients
|
gptkb:cimetidine
|
|
gptkbp:interacts_with
|
gptkb:phenytoin
gptkb:theophylline
gptkb:warfarin
benzodiazepines
|
|
gptkbp:is_atype_of
|
A02 B A01
|
|
gptkbp:is_available_on
|
generic version
|
|
gptkbp:is_used_for
|
treating gastroesophageal reflux disease (GERD)
treating ulcers
|
|
gptkbp:legal_issue
|
OTC
|
|
gptkbp:lifespan
|
2 hours
|
|
gptkbp:manager
|
oral
|
|
gptkbp:manufacturer
|
gptkb:Glaxo_Smith_Kline
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:packaging
|
blister pack
|
|
gptkbp:scholarships
|
avoid alcohol
take with food
do not exceed recommended dose
consult doctor if pregnant
report any unusual symptoms
|
|
gptkbp:side_effect
|
dizziness
headache
nausea
confusion
diarrhea
|
|
gptkbp:social_structure
|
C10 H13 N5 S
|
|
gptkbp:storage
|
room temperature
|